Hinge Health, Inc.· HNGE
🇺🇸 US · MidBroad USNYSE
- Price
- $79.42
- Day
- +2.28%
- Mkt Cap
- $6.15B
- 52W Range
- $30.08 – $91.50
- Volume
- 1.81M
- Beta
- 1.28
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today the publication of a new study that showed a significant reduction in the risk of falls and emergency room (ER) visits among adults aged 65+.The study, published in the Journal of Comparative Effectiveness Research, found that among adults aged 65+ at risk for falls, those using Hinge Health reported 37% fewer falls and 57% lower odds of reporting an ER visit at three months compared to a control group. They also rep.
Read full article
Hinge Health, Inc. (NYSE: HNGE) announced today the publication of a new study that showed a significant reduction in the risk of falls and emergency room (ER)
Read full article
Hinge Health Inc. (HNGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
Hinge Health has delivered an impressive near-50% rally in just over six weeks. I initially highlighted HNGE's 85% gross margins and innovative migraine care program as key growth drivers. The growth story remains compelling, but after the rapid appreciation, I am downgrading HNGE from 'strong buy' to 'buy.'
Read full article
� 2025 Benzinga.com. Benzinga does not provide investment advice.
Read full article
Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.
Read full article